Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Vitamin D3 + vitamin K2 (MK-7)

Vitamin D3 + K2 (MK-7 / Menaquinone-7) · also known as Vitamin D3 + K2, Cholecalciferol, MK-7, D3 and K2 calcium-to-bone combo

Vitamin D3 is converted in the body to its active form, which binds the VDR inside cell nuclei and regulates calcium absorption and some immune genes. K2 is a cofactor for carboxylation of vitamin K-dependent proteins, but its role in preventing vascular calcification has not been established.

Typical dose: Vitamin D3 is commonly taken at 2000–5000 IU/day and K2 (MK-7) at 100–200 μg/day, with a meal that contains fat. 5000 IU/day is above the usual tolerable upper intake level for US adults (4000 IU/day); long-term use should be guided by a doctor based on how deficient you are, with regular monitoring.
Absorption and forms: Vitamin D3 is fat-soluble, so taking it with a fat-containing meal helps absorption. For K2, choose all-trans MK-7 from a natural fermentation source such as chickpea. Its half-life is 72 hours, far longer than that of ordinary MK-4.

Clinical uses and human evidence

Vitamin D deficiency

BeneficialGrade B · Moderate evidence
Studies (1)
  1. Bhagatwala 2015 · BMC Obes · RCT · n=70 — Dose and time responses of vitamin D biomarkers to monthly vitamin D3 supplementation in overweight/obese African Americans with suboptimal vitamin d status: a placebo controlled randomized clinical trial

Bone density

Mixed resultsGrade B · Moderate evidence
Studies (2)
  1. Zhang 2020 · Calcif Tissue Int · RCT · n=311 — Effect of Low-Dose Vitamin K2 Supplementation on Bone Mineral Density in Middle-Aged and Elderly Chinese: A Randomized Controlled Study
  2. Rønn 2021 · Osteoporos Int · RCT · n=142 — The effect of vitamin MK-7 on bone mineral density and microarchitecture in postmenopausal women with osteopenia, a 3-year randomized, placebo-controlled clinical trial

Heart attack, stroke and other cardiovascular events

Mixed resultsGrade B · Moderate evidence
Studies (3)
  1. Diederichsen 2022 · Circulation · RCT · n=389 — Vitamin K2 and D in Patients With Aortic Valve Calcification: A Randomized Double-Blinded Clinical Trial
  2. Hasific 2023 · JACC Adv · RCT · n=304 — Effects of Vitamin K2 and D Supplementation on Coronary Artery Disease in Men: A RCT
  3. Hasific 2026 · Circulation · RCT · n=400 — Vitamin K(2) and D(3) Supplementation in Patients With Severe Coronary Artery Calcification: The DANCODE Trial

Falls in older adults

Mixed resultsGrade B · Moderate evidence
Studies (2)
  1. Massé 2026 · BMJ · Meta-analysis · n=153902 — Calcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis
  2. Appel 2021 · Ann Intern Med · RCT · n=688 — The Effects of Four Doses of Vitamin D Supplements on Falls in Older Adults : A Response-Adaptive, Randomized Clinical Trial

All-cause mortality risk

Mixed resultsGrade C · Preliminary evidence
Studies (2)
  1. Diederichsen 2022 · Circulation · RCT · n=389 — Vitamin K2 and D in Patients With Aortic Valve Calcification: A Randomized Double-Blinded Clinical Trial
  2. Hasific 2026 · Circulation · RCT · n=400 — Vitamin K(2) and D(3) Supplementation in Patients With Severe Coronary Artery Calcification: The DANCODE Trial

Low mood

No benefitGrade B · Moderate evidence
Studies (1)
  1. Okereke 2020 · JAMA · RCT · n=18353 — Effect of Long-term Vitamin D3 Supplementation vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial

Mechanisms of action

Vitamin D receptor (VDR) nuclear transcription and targeted calcium deposition

★★★★★Mechanism evidence: grade A

Active vitamin D binds the VDR in the cell nucleus and regulates genes such as those for calcium transport. K2 (MK-7) is a cofactor for the carboxylation of osteocalcin and matrix Gla protein, and randomized human trials have measured improved carboxylation markers. This does not mean the combination can steer calcium into bone or prevent vascular calcification.

References (2)
  1. Inaba et al. 2015 · Human RCT: MK-7 at 100 μg/day improved osteocalcin carboxylation markers
  2. Theuwissen et al. 2012 · Human randomized dose trial: MK-7 improved the carboxylation status of circulating osteocalcin and matrix Gla protein

Pattern recognition receptor (PRR) immune surveillance and trained immunity

★★☆☆☆Mechanism evidence: grade BSecondary target

Active vitamin D can regulate some innate immune genes. In human studies, TLR-related serum markers changed after D3 supplementation, but in some studies LL-37 transcription was not significantly higher than in controls. D3 itself has not been confirmed as a TLR ligand that mimics pathogens.

References (2)
  1. Arifin et al. 2023 · Small RCT in patients with spinal tuberculosis: serum TLR2/TLR4 markers changed after vitamin D supplementation, which does not directly show receptor activation
  2. Human randomized trial 2014 · Vitamin D-deficient women: after D3 supplementation, LL-37 transcription in peripheral blood mononuclear cells was not significantly higher than in controls

Safety and drug interactions

Contraindicated in people with primary hyperparathyroidism and severe hypercalcemia. People taking anticoagulants such as warfarin need close monitoring: even low-dose K2 may affect warfarin's anticoagulant effect, so coordinate with the clinician managing anticoagulation and monitor INR before starting, stopping or adjusting the dose.

With Anticoagulants High risk

Warfarin, rivaroxaban, apixaban, dabigatran

Vitamin K2 directly counteracts warfarin, so people taking warfarin should not take it without their doctor’s agreement (warfarin only).

With Antihypertensive drugs Note

Amlodipine, valsartan, benazepril, metoprolol, hydrochlorothiazide

Thiazide diuretics reduce calcium loss in urine, so taking high-dose vitamin D at the same time may raise blood calcium. The risk is higher with poor kidney function or parathyroid disease. Consider checking blood calcium periodically (thiazide diuretics only).

With Digoxin Needs attention

Digoxin

If high-dose vitamin D raises blood calcium, the risk of digoxin-induced arrhythmia goes up. People on digoxin who take vitamin D should have their blood calcium checked regularly.

With Diuretics Needs attention

Furosemide, torsemide, hydrochlorothiazide, indapamide

Thiazide diuretics reduce the amount of calcium lost in urine, and high-dose vitamin D may raise blood calcium; the risk is greater with poor kidney function or parathyroid disease. Blood calcium can be checked periodically (thiazide diuretics only).

Related lab tests

25-hydroxyvitamin D Test before supplementing

Common doses of 2000–5000 IU/day approach or exceed the usual adult upper limit of 4000 IU. Before long-term high-dose use, it is best to test once and set the dose by how deficient the person is. Preventive supplementation at the recommended amount does not need a test first.

25-hydroxyvitamin D Recheck while taking

On high-dose supplementation, you can recheck once at about 3 months to see whether you have reached the target and whether you are getting too much. Once the dose is stable, repeat testing is usually not needed.

Calcium Recheck while taking

Vitamin D supplements may unmask hypercalcemia that was previously hidden. After starting a high dose (around 5000 IU/day), check blood calcium about 1 month later.

Open in the interactive app ›